V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20157756 | 20060279 | 1.76 | 86.7 | Curative (C) | 2019-04-26 | 2019-04-29 | ECX | N | N | ECX | 101843071 |
| 20157758 | 20060280 | 1.67 | 47.8 | Neo-adjuvant (N) | 2019-01-29 | 2019-01-29 | ECX | N | N | ECX | 100556557 |
| 20157760 | 20060281 | 1.86 | 70 | Palliative (P) | 2019-06-12 | 2019-06-18 | ECX | N | N | ECX | 100522949 |
| 20157761 | 20060282 | 1.78 | 51 | Curative (C) | 2019-11-23 | 2019-12-08 | ECX | N | N | ECX | 101640246 |
| 20157762 | 20060283 | 1.57 | 49 | Adjuvant (A) | 2018-07-31 | 2018-08-06 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100128560 |
| 20157763 | 20060284 | 1.49 | 60.7 | Adjuvant (A) | 2019-12-13 | 2019-12-13 | ECX | 2 | N | ECX | 100301323 |
| 20157765 | 20060285 | null | null | Palliative (P) | 2017-03-13 | 2017-03-31 | ECX | N | N | ECX | 100341213 |
| 20157766 | 20060286 | 1.7 | 88 | Adjuvant (A) | 2018-05-20 | 2018-06-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101198953 |
| 20157767 | 20060287 | 1.5 | 77.6 | Palliative (P) | 2016-07-03 | 2016-07-17 | ECX | null | null | CAPECITABINE + GEMCITABINE | 101250973 |
| 20157772 | 20060288 | 1.68 | 76.4 | Palliative (P) | 2017-04-01 | 2017-04-01 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 100227483 |
| 20157773 | 20060289 | 1.73 | 65.1 | Neo-adjuvant (N) | 2019-10-08 | 2019-10-09 | ECX | 02 | N | ECX | 101141729 |
| 20157774 | 20060290 | 1.62 | 66.2 | Adjuvant (A) | 2018-06-06 | 2018-06-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100643776 |
| 20157775 | 20060291 | 1.62 | 59 | Adjuvant (A) | 2017-04-11 | 2017-04-14 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100162003 |
| 20157776 | 20060292 | 1.83 | 56.8 | Neo-adjuvant (N) | 2017-02-27 | 2017-02-27 | ECX | 02 | N | ECX | 100507683 |
| 20157778 | 20060293 | 1.61 | 66.5 | Palliative (P) | 2018-07-29 | 2018-07-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101460837 |
| 20157779 | 20060294 | 1.81 | 59.4 | Adjuvant (A) | 2018-03-15 | 2018-03-25 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101654560 |
| 20157780 | 20060295 | 1.76 | 113 | Curative (C) | 2017-03-03 | 2017-04-14 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100294120 |
| 20157781 | 20060296 | 1.61 | 59.8 | Palliative (P) | 2017-11-14 | 2017-12-04 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100469781 |
| 20157782 | 20060297 | 1.76 | 69 | Palliative (P) | 2020-01-01 | 2020-01-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100933564 |
| 20157787 | 20060298 | 1.6 | 79.3 | Adjuvant (A) | 2017-12-23 | 2018-01-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101482122 |
| 20157789 | 20060299 | 1.59 | 73.35 | Adjuvant (A) | 2019-05-07 | 2019-05-16 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100094882 |
| 20157790 | 20060300 | 1.49 | 64.6 | Curative (C) | 2017-05-19 | 2017-06-07 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101591960 |
| 20157791 | 20060301 | 1.76 | 58.6 | Neo-adjuvant (N) | 2019-11-07 | 2019-11-27 | ECX | 2 | N | ECX | 100145228 |
| 20157794 | 20060302 | 1.63 | 54.8 | Neo-adjuvant (N) | 2016-11-10 | 2016-11-22 | ECX | 02 | null | ECX | 100571685 |
| 20157795 | 20060303 | 1.59 | 65.6 | Neo-adjuvant (N) | 2019-04-30 | 2019-05-13 | ECX | N | N | ECX | 100578626 |
| 20157796 | 20060304 | 1.8 | 48.4 | Adjuvant (A) | 2019-05-31 | 2019-06-22 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100560998 |
| 20157797 | 20060305 | null | null | Adjuvant (A) | 2017-09-13 | 2017-10-01 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101256345 |
| 20157799 | 20060306 | null | null | Palliative (P) | 2016-05-02 | 2016-05-22 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100258633 |
| 20157800 | 20060307 | 1.5 | 70.75 | Adjuvant (A) | 2018-12-25 | 2019-01-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100573818 |
| 20157801 | 20060308 | 1.66 | 69.4 | Neo-adjuvant (N) | 2019-12-26 | 2019-12-29 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100768430 |
| 20157803 | 20060309 | 1.53 | 74.8 | Neo-adjuvant (N) | 2018-01-01 | 2018-01-12 | ECX | N | N | ECX | 100273555 |
| 20157804 | 20060310 | 1.76 | 75.8 | Neo-adjuvant (N) | 2018-05-21 | 2018-06-15 | ECX | N | N | ECX | 100000015 |
| 20157806 | 20060311 | 1.63 | 106 | Adjuvant (A) | 2018-05-02 | 2018-05-08 | ECX | 02 | N | ECX | 100992905 |
| 20157807 | 20060312 | 1.63 | 83 | Neo-adjuvant (N) | 2016-09-17 | 2016-10-15 | ECX | N | N | ECX | 101441301 |
| 20157808 | 20060313 | 1.67 | 91.8 | Adjuvant (A) | 2019-05-31 | 2019-05-31 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101740998 |
| 20157809 | 20060314 | 1.57 | 76.5 | null | 2017-06-18 | 2017-07-28 | ECX | N | N | ECX | 100008677 |
| 20157810 | 20060315 | 1.67 | 74.8 | Adjuvant (A) | 2017-12-15 | 2018-01-12 | CAPECITABINE + GEMCITABINE | N | null | CAPECITABINE + GEMCITABINE | 101166030 |
| 20157812 | 20060316 | null | 65.6 | Palliative (P) | 2018-06-30 | 2018-07-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101514418 |
| 20157814 | 20060317 | 1.9 | 81 | Palliative (P) | 2019-09-06 | 2019-09-22 | ECX | N | N | ECX | 100453877 |
| 20157815 | 20060318 | 1.65 | 126.2 | Palliative (P) | null | 2019-10-12 | ECX | null | N | ECX | 101275143 |
| 20157817 | 20060319 | 1.64 | 64 | Palliative (P) | 2018-07-30 | 2018-08-14 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101506299 |
| 20157818 | 20060320 | 1.73 | 72 | Adjuvant (A) | 2016-05-23 | 2016-05-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101853074 |
| 20157822 | 20060321 | 1.72 | 86 | Adjuvant (A) | 2017-12-10 | 2017-12-11 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101834850 |
| 20157824 | 20060322 | 1.65 | 73 | Palliative (P) | 2017-08-28 | 2017-08-28 | ECX | 02 | N | ECX | 101726864 |
| 20157826 | 20060323 | 1.97 | 87 | null | 2018-08-08 | 2018-08-19 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100119966 |
| 20157828 | 20060324 | 1.71 | 56.45 | null | 2017-11-19 | 2017-11-26 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100920542 |
| 20157829 | 20060325 | 1.82 | 74 | Curative (C) | 2017-12-31 | 2018-01-16 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100405232 |
| 20157830 | 20060326 | 1.73 | 69.2 | Palliative (P) | 2018-03-18 | 2018-04-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100635087 |
| 20157831 | 20060327 | 1.81 | 83 | null | 2018-03-19 | 2018-04-02 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 101758637 |
| 20157834 | 20060328 | 1.67 | 67.5 | Palliative (P) | 2019-03-28 | 2019-03-31 | ECX | N | N | ECX | 101864538 |